Caroline Amalia Nebhan

Caroline Nebhan practices at Intermountain Medical Oncology-Imc in Salt Lake City, Utah.

Caroline Nebhan's NPI, 1053766329, was assigned on April 25, 2016. Caroline Nebhan graduated from Vanderbilt University School Of Medicine in 2016. Caroline Nebhan holds Utah license 12682794-1205.

Caroline Nebhan's primary practice is Intermountain Medical Oncology-Imc, at 5171 S Cottonwood St, Salt Lake City, UT 84107 in Salt Lake County. The practice phone is (801) 507-3630.

Caroline Nebhan's primary practice is Intermountain Medical Oncology-Imc in Salt Lake City, Utah. Caroline Nebhan is also affiliated with LDS Hospital. The medical group on file is Intermountain Health. Dmand AI also links Caroline Nebhan to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Caroline Nebhan practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Caroline Nebhan's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Caroline Nebhan's licenses on file in 2 states: Utah and Tennessee.

CMS data shows 777 Medicare services from Caroline Nebhan across 6 procedure codes in 2024, for 81 Medicare patients. Medicare paid $53,556 for them. Every service was in an office.

CMS counts 81 Medicare patients who saw Caroline Nebhan in 2024. The largest group is 65 to 74, with 37 patients. 75% of them have high blood pressure, and 60% have high cholesterol. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Caroline Nebhan's median patient age at 71, with 41% women.

In 2024, Caroline Nebhan wrote 411 Medicare Part D claims for 81 patients. 84% of them were for generic drugs. CMS names the drug for 252 of them, across 8 drugs with 11 or more claims each, at $206,661 in total drug cost. In 2023, CMS named 146 claims across 6 drugs.

Caroline Nebhan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Caroline Nebhan as offering telehealth.

Dmand AI links 26 papers to Caroline Nebhan, published from 2010 to 2023. 2021 was the busiest year, with 4. The most frequent topics are Lung Neoplasms, Immune Checkpoint Inhibitors and Melanoma. Caroline Nebhan has published most often in Cancer Discov. Caroline Nebhan's most frequent co-authors are Michael A. Davies, MD, PhD, Vincent A. Miller, MD and Jeffrey A. Sosman, MD.

CMS Open Payments shows 5 general payments to Caroline Nebhan from 5 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 100% of the total. Telix Pharmaceuticals paid the most, $140.

Caroline Nebhan graduated from Vanderbilt University School Of Medicine in 2016.